Macrophages restrict Pseudomonas aeruginosa growth, regulate polymorphonuclear neutrophil influx, and balance pro- and anti-inflammatory cytokines in BALB/c mice

J Immunol. 2003 May 15;170(10):5219-27. doi: 10.4049/jimmunol.170.10.5219.

Abstract

The role of macrophages in Pseudomonas aeruginosa corneal infection in susceptible (cornea perforates), C57BL/6 (B6) vs resistant (cornea heals), BALB/c mice was tested by depleting macrophages using subconjunctival injections of clodronate-containing liposomes before corneal infection. Both groups of inbred mice treated with clodronate-liposomes compared with PBS-liposomes (controls) exhibited more severe disease. In B6 mice, the cornea perforated and the eye became extremely shrunken, whereas in BALB/c mice, the cornea perforated rather than healed. The myeloperoxidase assay detected significantly more PMN in the cornea of both groups of mice treated with clodronate-liposomes vs PBS-liposomes. In independent experiments, ELISA analysis showed that protein levels for IL-1 beta, macrophage-inflammatory protein 2, and macrophage-inflammatory protein 1 alpha, all regulators of PMN chemotaxis, also were elevated in both groups of mice treated with clodronate-liposomes. Bacterial plate counts in B6 mice treated with clodronate-liposomes were unchanged at 3 days and were higher in control-treated mice at 5 days postinfection (p.i.), whereas in BALB/c mice, bacterial load was significantly elevated in the cornea of mice treated with clodronate-liposomes at both 3 and 5 days p.i. mRNA expression levels for pro (IFN-gamma and TNF-alpha)- and anti (IL-4 and IL-10)-inflammatory cytokines also were determined in BALB/c mice treated with clodronate-liposomes vs control-treated mice. Expression levels for IFN-gamma were significantly elevated in mice treated with clodronate-liposomes at 3 and 5 days p.i., while IL-10 levels (mRNA and protein) were reduced. These data provide evidence that macrophages control resistance to P. aeruginosa corneal infection through regulation of PMN number, bacterial killing and balancing pro- and anti-inflammatory cytokine levels.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Chemokines / biosynthesis
  • Clodronic Acid / administration & dosage
  • Colony Count, Microbial
  • Conjunctiva
  • Cornea / drug effects
  • Cornea / immunology
  • Cornea / microbiology
  • Cornea / pathology
  • Cytokines / antagonists & inhibitors
  • Cytokines / biosynthesis*
  • Cytokines / genetics
  • Eye Infections, Bacterial / immunology
  • Eye Infections, Bacterial / metabolism
  • Eye Infections, Bacterial / microbiology
  • Eye Infections, Bacterial / pathology
  • Female
  • Immunosuppression Therapy
  • Inflammation Mediators / metabolism*
  • Interleukin-10 / antagonists & inhibitors
  • Interleukin-10 / biosynthesis
  • Interleukin-10 / genetics
  • Leukocyte Count
  • Macrophages / drug effects
  • Macrophages / immunology*
  • Macrophages / microbiology*
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Neutrophil Infiltration / drug effects
  • Neutrophil Infiltration / immunology*
  • Pseudomonas Infections / immunology*
  • Pseudomonas Infections / metabolism
  • Pseudomonas Infections / pathology*
  • Pseudomonas aeruginosa / growth & development
  • Pseudomonas aeruginosa / immunology*
  • RNA, Messenger / antagonists & inhibitors
  • RNA, Messenger / biosynthesis
  • Th1 Cells / immunology
  • Th1 Cells / metabolism
  • Th2 Cells / immunology
  • Th2 Cells / metabolism

Substances

  • Chemokines
  • Cytokines
  • Inflammation Mediators
  • RNA, Messenger
  • Clodronic Acid
  • Interleukin-10